SCOPUS 정보 검색 플랫폼

Clinical Infectious Diseases

Volumn 51, Issue 7, 2010, Pages 870-

Oral voriconazole dose in children: One size does not fit all

(5) Goutelle, Sylvain a,c Larcher, Romaric d Padoin, Christophe e Mialou, Valérie b Bleyzac, Nathalie b,c

a Pierre Garraud Hospital (France)

b University Medical Hospital of Lyon (France)

c UNIVERSITÉ LYON 1 (France)

d MONTPELLIER UNIVERSITY HOSPITAL (France)

e AVICENNE HOSPITAL (France)

Author keywords

[No Author keywords available]

Indexed keywords

VORICONAZOLE;

ADOLESCENT; ADULT; BODY WEIGHT; CHILD; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG MONITORING; HOSPITAL PATIENT; HUMAN; LETTER; OPTIMAL DRUG DOSE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 77957827694 PISSN: 10584838 EISSN: None Source Type: Journal
DOI: 10.1086/656293 Document Type: Letter

Times cited : (11)

References (6)

1
- 72049130592
- Voriconazole pharmacokinetics and pharmacodynamics in children
- Neely M, Rushing T, Kovacs A, Jelliffe R, Hoffman J. Voriconazole pharmacokinetics and pharmacodynamics in children. Clin Infect Dis 2010; 50:27-36.
- (2010) Clin Infect Dis , vol.50 , pp. 27-36
- Neely, M.¹ Rushing, T.² Kovacs, A.³ Jelliffe, R.⁴ Hoffman, J.⁵

2
- 2542443542
- Pharmacokinetics and safety of intravenous voriconazole in children after single- Or multiple-dose administration
- DOI 10.1128/AAC.48.6.2166-2172.2004
- Walsh TJ, Karlsson MO, Driscoll T, et al. Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration. Antimicrob Agents Chemother 2004; 48:2166-2172. (Pubitemid 38691615)
- (2004) Antimicrobial Agents and Chemotherapy , vol.48 , Issue.6 , pp. 2166-2172
- Walsh, T.J.¹ Karlsson, M.O.² Driscoll, T.³ Arguedas, A.G.⁴ Adamson, P.⁵ Saez-Llorens, X.⁶ Vora, A.J.⁷ Arrieta, A.C.⁸ Blumer, J.⁹ Lutsar, I.¹⁰ Milligan, P.¹¹ Wood, N.¹²

3
- 62949105433
- Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies
- Karlsson MO, Lutsar I, Milligan PA. Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies. Antimicrob Agents Chemother 2009; 53:935-944.
- (2009) Antimicrob Agents Chemother , vol.53 , pp. 935-944
- Karlsson, M.O.¹ Lutsar, I.² Milligan, P.A.³

4
- 39449117139
- Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes
- DOI 10.1086/524669
- Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis 2008; 46:201-211. (Pubitemid 351269158)
- (2008) Clinical Infectious Diseases , vol.46 , Issue.2 , pp. 201-211
- Pascual, A.¹ Calandra, T.² Bolay, S.³ Buclin, T.⁴ Bille, J.⁵ Marchetti, O.⁶

5
- 57749084153
- Therapeutic drug monitoring of voriconazole
- Bruggemann RJ, Donnelly JP, Aarnoutse RE, et al. Therapeutic drug monitoring of voriconazole. Ther Drug Monit 2008; 30:403-411.
- (2008) Ther Drug Monit , vol.30 , pp. 403-411
- Bruggemann, R.J.¹ Donnelly, J.P.² Aarnoutse, R.E.³

6
- 77957828050
- Population pharmacokinetics of voriconazole in patients with invasive mycoses
- Presented at: Abstract 1564. Accessed 30 April 2010
- Csajka C, Pascual A, Bolay S, et al. Population pharmacokinetics of voriconazole in patients with invasive mycoses. Presented at: 2009 Population Approach Group in Europe Annual Meeting. Abstract 1564. http://www.page-meeting. org/default.asp?abstractp1564. Accessed 30 April 2010.
- 2009 Population Approach Group in Europe Annual Meeting
- Csajka, C.¹ Pascual, A.² Bolay, S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.